Venus Remedies has extended its footprint in Latin America with marketing authorisation for meropenem from Venezuela.
Pawan Chaudhary, Chairman and Managing Director, Venus Remedies said, “We are planning to launch meropenem in Venezuela in the next couple of months. The $10-million meropenem market in Venezuela offers a great opportunity to us and we are aiming at capturing a sizeable share in this market in the first year of the launch. Having a presence in important Latin American markets like Columbia, Peru, Guatemala and Mexico, we are constantly strengthening our position in Latin America.”
Meropenem, which accounts for annual global sales of $906 million which are estimated to go up to $1,006 million in the next one year, is an off-patented antibacterial agent of the carbapenem class of antibiotics, which caters to diseases with a broad range of serious infections.
EP News Bureau – Mumbai